Artificial Intelligence | Machine Learning | Natural Language Processing Sweetch | Chronic Disease & Health Care


Consumer, Prevention and Management of Chronic Disease , Healthcare, Digital Health, Doctors Jerusalem, Yerushalayim, Israel

Sweetch

Artificial Intelligence | Machine Learning | Natural Language Processing


Sweetch | Chronic Disease & Health Care

Sweetch

Prevention and Management of Chronic Disease , Healthcare, Digital Health, Doctors


Jerusalem, Yerushalayim, Israel

Sweetch is an Artificial Intelligence based platform for large scale prediction, prevention and outcome improvement of chronic diseases - diabetes, hypertension, hyperlipidemia, and obesity. They believe that every individual should live a healthier lifestyle. Currently, no scalable and cost-effective solution exists that helps the prediabetic population, therefore providing some sort of guidance is vital. Sweetch reduces the risk of diabetes and improves outcomes of chronic diseases by implementing a personalized intervention that focuses on emotional support and motivation to drive behavior change.

Sweetch is a game-changing platform that predicts personal diabetes risk and drives long-term behavioral change to prevent diabetes in a way never seen before. Sweetch was developed as a platform for any large-scale clinical outcome prediction, and personalized, data-driven, wellness prevention intervention in the most cost-effective patients. Diabetes is our first use case.

 

B2C, B2B

1 to 25

Series A

$15,532,000

Scaling Up

2013

 
 

Managed Health Care
Healthcare
Health Care Facilities & Hospitals

N/A

Increase Efficiency

 
 

Analytics
IT and Security
Service

Yes

Active

 
 

   Machine Learning
   Natural Language Processing


Contextual Realtime Recommendations

Contextual Realtime Recommendations

Contextual Realtime Analysis

Contextual Realtime Analysis

Predictive Analytics

Predictive Analytics


N/A

 

   Software


NA

NA


NA

NA

 
 

7

1

$20 M

Company was founded 2013 and it took almost 8 years (Jul 2021) to raise first external round

 
 

Date

Round

$ Raised

Investors

07/19/2021

Series A

$20 M

Entrée Capital, Tal Capital, Noaber, Kortex Ventures, FinTLV Ventures, OurCrowd, Qure Ventures

Date : 07/19/2021

Round: Series A

$ Raised: $20 M

Investors: Entrée Capital, Tal Capital, Noaber, Kortex Ventures, FinTLV Ventures, OurCrowd, Qure Ventures

 
 
Dana Chanan


Dana Chanan
CEO

Dan Lichtenfeld


Dan Lichtenfeld
CEO & Co-Founder